Cortagen 20mg 10vials

Description

Cortagen Brain Peptide Bioregulator Neural Repair Research

Mechanism Overview

The biochemical activity of this compound relies on its capability to penetrate the cell matrix and interact directly with the nuclear apparatus of cortical cells. The primary mechanism involves the short-chain tetramer crosses the blood-brain barrier via passive diffusion and enters the neuronal nucleus. This defines the first semantic triple: [Cortagen penetrates the neuronal nucleus]. Secondly, the peptide binds to specific promoter regions of double-stranded DNA, inducing a structural unwinding of heterochromatin. This establishes the second triple: [Cortagen binding decondenses heterochromatin]. Thirdly, this targeted epigenetic reconfiguration reactivates silenced genes, directly upregulating the transcription of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). This forms the third triple: [Chromatin modification increases neurotrophin transcription]. Quantitatively, while Cortagen exhibits a short plasma half-life of approximately 20 minutes ($t_{1/2} = 20.0 pm 4.0$ min) due to rapid serum aminopeptidase cleavage, it initiates a prolonged downstream transcriptional cascade that alters cellular protein synthesis for up to 48 hours. In comparative studies, Cortagen is distinguished from the complex peptide mixture Cerebrolysin; while Cerebrolysin contains a broad, non-standardized array of neurotrophic factors and amino acids, Cortagen represents a single, highly defined active chemical isolate that strictly targets cortical chromatin remodeling without secondary systemic interactions.

Chemical Properties

• Amino Acid Sequence: Ala-Glu-Asp-Pro (AEDP)
• CAS Number: 908316-24-9
• Molecular Formula: C16H24N4O9
• Molecular Weight: 416.38 g/mol
• Purity: >99.0% via HPLC-UV
• Appearance: Sterile white lyophilized powder cake

Reported Findings

• Accelerated Neuro-Metabolic Recovery: Users in research models report a pronounced reduction in cognitive deficits following induced ischemic or mechanical stress.
• Enhanced Synaptic Plasticity: Experimental findings suggest marked improvements in long-term potentiation markers and memory consolidation vectors.
• Cortical Inflammatory Modulation: As documented in protocols, research models show a substantial down-regulation of pro-inflammatory interleukins within neural tissue.
• DNA Structural Rejuvenation: Cross-study analysis suggests that the peptide shifts old, highly condensed chromatin states toward a youthful profile.
• Optimized Stress Resilience: Research models have observed stabilized emotional and behavioral markers under chronic environmental duress.

Product Profile

Cortagen is a synthetic tetramer peptide designed to modulate structural and functional profiles within the cerebral cortex. [Cortagen upregulates neurotrophic factor expression]. This ultra-pure short bioregulator serves as a primary research benchmark for investigating neuroprotection, chromatin activation, and the deceleration of age-dependent cortical involution. Its minimalist peptide architecture allows for high-fidelity studies on targeted gene expression and DNA-protein interactions without structural steric hindrance.

In Brief:
Cortagen represents a premier, targeted short peptide research tool for investigating the direct epigenetic regulation of neurotrophic factors and the molecular pathways of cortical restoration.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.